The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...

The prospective multi-centre BIO-LivIQ trial will enrol 325 patients across 60 sites worldwide.

International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals; Far-Field Sensing and ...

JANESVILLE, Wis. -- Two Mercyhealth hospitals performed its first dual leadless pacemaker procedures. Mercyhealth Hospital and Trauma Center-Janesville and Javon Bea Hospital-Riverside have each ...

Abbott's Aveir single chamber (VR) pacing system is the world's only leadless pacemaker with a unique mapping capability to assess correct positioning prior to placement Aveir VR has an increased ...

FRENO, Calif. (KFSN) -- The heart is a central organ that never stops. It pumps blood and carries oxygen and nutrients throughout our bodies. "The heart beats more than 100,000 times a day," says Dr.

The Cleveland Clinic announced their team successfully implanted the world's first leadless pacemaker defibrillator system in two patients. Pacemakers provide electrical stimulation to regulate a ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

ROCK ISLAND, Ill. — The Quad Cities’ first leadless pacemaker procedure was performed this summer at UnityPoint Health – Trinity Heart Center, marking a milestone in local heart care. The July 2025 ...

ROCK ISLAND, Ill. — A local patient this summer became the first in the Quad Cities to receive a leadless pacemaker at UnityPoint Health – Trinity Heart Center, marking a significant step in minimally ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA has approved its Aveir VR single-chamber leadless pacemaker for the treatment of ...

A leadless right-ventricular pacemaker continued to show an edge over conventional transvenous pacemakers by triggering a substantially reduced rate of complications during the 6 months following ...